StockClub
HTSUYHisamitsu Pharmaceutical Co., Inc.$ --
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUY

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2024 Full YearUpdated: 02/28/2025

Revenue

attach_money
1,023M USD
YoY +3.4%

Operating Income

bar_chart
124M USD
YoY +34.8%

Net Income

verified
143M USD
YoY +46.3%

EPS

pie_chart
0.48USD
YoY +50.0%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2024
Full-year forecast not available

Income Statement Details

Item
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
1,023
425
598
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
71
0
403
899
124
Interest expense
Income before tax
Income tax expense
Net income
0
188
42
143

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.